Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund
Singapore
LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.
European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund for early-stage investments.
TRENDING NOW
Two Singapore-listed palm oil firms named in Greenpeace report on Indonesian plantation fires
Singapore Airlines flight returns to San Francisco after ‘unruly’ passenger incident
Singapore looking into which companies responsible for haze-causing fires: PM Wong
Deluge IPO 3.86 times subscribed ahead of SGX debut